What is the levy per worker per year...

1000 each?

No need to make it complicated .

No need to argue unti the snake comes home

More foreign worker,more levy to the government.

Proven product attracts high fwd PE.

No saleable product,no PE....very simple....

Government pays for foreign workers..Government will get it back through higher levy on foreign workers.eventually,,com hiring foreign workers foot the bill

If no 100% efficacy then go for the one with least side effect.

Its common sense.even my dog also knows....

t is not a matter of being popular or not.its a matter of safety of the highest standard.

It is not a matter of cheapness or not ,its a matter of safety of the highest order.

That's why I say it is your choice. your life is in your own hand not mine..

Fwd EPS with Fwd PE can determine the expected TP....very simple

Forward PE need not depend on the past QR

Vaccine manufacturers still derive profit from sale of their Vaccine to WHO

WHO pays for it.

Market is forward looking.share price is reflected of the expected future growth not the past or current growth.future PE is used

Suggest you go back to basic before you make a fool of yourself.

It is not ready now doesn't mean its ready by new year...

Has the mou been terminated ? No.right? Right!

No breach ,no compensation. Business is as usual .agreement is binding.

Moh is a government machinery.wake up.bro.it doesn't enter into any mou of any kind.

Ular seems to have problem of listening....he hears but can't listen.

I maintain my stand where there is no 100% efficacy ( it never will be) then go for the one with least side effect

Honestly and personally speaking, I will not consider Pfizer and Oxford as my 1st choice. I am not too sure of moderna pending more facts to be made known.

No matter what and how you argue, the safest choice is the one which shows/ develops the least side effect

Who knows the side effect can make you become half past six faster? Its your choice..

You want to mess your life with it....it is your choice....

It is not a matter of being popular or not.its a matter of safety of the highest standard.

It is not a matter of cheapness or not ,its a matter of safety of the highest order.

That's why I say it is your choice. your life is in your own hand not mine...

Don't worry about 20% supply and or this..when your product is proven to be good ,no need to promote.it is saleable like hot cake.

Wanna me to buy you Xmas cake free? Its free to you but no free to me..ular

If no 100% efficacy then go for the one with least side effect

Honestly and personally speaking, I will not consider Pfizer and Oxford as my 1st choice. I am not too sure of moderna which I am still ascertaining facts from my reliable sources

Just because the Western worlds want to start the economy recovery fast, they compelled FDA to grant them with emergency approval in a hasty manner. The emergency approval is akin to temporary approval...WTH

As I have reiterated ,I go for the safest choice given a lot of choices....

China is very smart by not rushing to grant approval though they have put a large numbers of people over millions on trial within China and abroad like indo,Turkey,Pakistan, Brazil.

No side effect has been reported so far.

Now then it is waiting for the right time to strike .........

When???I tell you later

No need to argue ..all the vaccines except China ones have been reported with side effect...check the today news in USA and UK. Reported by prestigious press.

Floor plan of fill and finish has been approved by NPRA is better than no approval.setting up is in the progress and by new year ,it will be ready.

If you don't want to get complication after vaccination,better opt for the vaccine with least side effect.

The choice is yours.....heaven or hell

Calvin ,The more you say,the more preposterous it becomes ,the more you make a fool of yourself to the world.....

Calvin tan.Vaccine is given free to the people by the government or vaccine supplier?.

If such a simple question can not be answered by ypu what on earth do you think you can create havoc to this counter?

Free for all but government foot the bill.it is not given free of charge by the vaccine manufacturer

Calvin tan has no effect on the share price .you can't insult the intelligence of the readers company investors but yourself..

What matters most is the " proven.product " the company is distributing.if you got the proven product,every body will buy from u no matter how far

If you got the lousy product ,it doesn't matter how reputable your company is,no one will buy from you

There is no need to have fill and finish in each and every country, a country is selected as a central hub of distribution among Asian countries should suffice.

No proven product,no solution....

China government is not involved in marketing.. they only approve and registere the vaccines developed by company.(vaccine manufacturer)

Who are the authorised distributors in the respective Asian countries?.can you name them,? Basically None..why ? Vaccine manufacturers don't simply appoint Tom, dick and Harry as their authorised distributors..

Who is stupid?

Thats why I say if Malaysia doesn't buy,plenty will buy......

Total population of Philippines and Indonesia is 370m +++. 12 times of Malaysia....

So why worry? Only trolls are worried

Government can say whatever it wants. Suppliers manufacturer can not say what it wants cos it is bounded by agreement...too bad...

Government can u turn...vaccine manufacturers can't u- turn otherwise hefy compensation will be paid

agreement signed whether you like it or not. No u-turn..You don't buy, plenty will....

Through Authorised supplier..thats the way of distribution whether you like it or not....


The government 's reluctance of not buying is larger than the economic loss of the nation.

i bet the government is sensible enough to make the the sensible decision.

Solution is of no nonsense. They mean biz..

There is another mou to supply to Asian countries...later show u

We accept what is good and reject what is bad objectively without prejudice..

As simple as that...

Zuliana.

No really.. lim of kossan recently sold a small portion of share but he still remains the major shareholder who is still helming the company and he is still in control.

Bursa permits directors to sell and buy shares openly and freely .that's the beauty of plc..no big deal.today they sell and next day they can buy back and so on ......

Open up your mind and see. Your problem is that u look but your don't see and jump into conclusion within your context....

Correct

Otherwise .you make yourself look like a fool

We don't belittle others but pl get your facts right.

Don't simply input with emotions

Wake up zuliana

The total disposal by director is only 0.276% which is insignificant as compared to his total shareholding of more than 25%....(direct and indirect)

Oxford or not Oxford doesn't matter.what matters its efficacious with least side effect.

For any kind of drug,I always go for the one with least side effect unless you have no choice..

Since you have the choice,why choose the stupid choice.....of course,the choice is yours....

Zuliana,

*No need to belittle others
*No need to show off how great you have been with your narrow escape.we can assure your narrow escape will not be the last
*We move on and don't live under the shadow of the past
*You don't represent the gov for any procurement
*The government is not stupid to gamble the health risk of its population by simply taking any vaccine to suit its agenda.
* none of the vaccine would claim 100% efficacy
*hence the vaccine with least side effect should be opted for as a wise move
*you have the absolute right to choose your vaccine as you have the right to choose to go to heaven or hell.

Zuliana can't even distinguish the role of non-executive and executive directors....how to invest?

@JoyvestImbecile The contents of the doucments said that joyvest mom is going to be a prostitute for bangla workers at rm 4 a shot..anyone believe
_______________________________________________

U are abusive and offensive to insult the family member of the member in this forum here

You are a scumbag.

You will be dealt with accordingly.

Anyone can buy and sell shares open market.nk big deak

It's free to us anyway.my only concern is which one has the least side effect.......

No one dare to claim 100 % efficacy....

The above tells you which one is cheaper and efficacious.

Ultra.. any more questions?

LONDON (AP) — Drugmaker AstraZeneca said Monday that late-stage trials showed its COVID-19 vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world.

The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca. No hospitalizations or severe cases of COVID-19 were reported in those receiving the vaccine.

AstraZeneca is the third major drug company to report late-stage data for a potential COVID-19 vaccine as the world waits for scientific breakthroughs that will end a pandemic that has pummeled the world economy and led to 1.4 million deaths. But unlike the others, the Oxford-AstraZeneca vaccine doesn’t have to be stored at freezer temperatures, making it potentially easier to distribute, especially in developing countries.

“I think these are really exciting results,” Dr. Andrew Pollard, chief investigator for the trial, said at a news conference. “Because the vaccine can be stored at fridge temperatures, it can be distributed around the world using the normal immunization distribution system. And so our goal … to make sure that we have a vaccine that was accessible everywhere, I think we’ve actually managed to do that.”

MORE COVID-19 NEWS:
– FDA allows emergency use of antibody drug Trump received
– The Latest: China reports results of mass testing
– China tests millions after coronavirus flareups in 3 cities
The Oxford-AstraZeneca vaccine was 90% effective in preventing COVID-19 in one of the dosing regimens tested; it was less effective in another. Earlier this month, rival drugmakers Pfizer and Moderna reported preliminary results from late-stage trials showing their vaccines were almost 95% effective.

While the AstraZeneca vaccine can be stored at 2 degrees to 8 degrees Celsius (36 degrees to 46 degrees Fahrenheit), the Pfizer and Moderna products must be stored at freezer temperatures. In Pfizer’s case, it must be kept at the ultra-cold temperature of around minus-70 degrees Celsius (minus-94 Fahrenheit).

The AstraZeneca vaccine is also cheaper.

Youtube video thumbnail
AstraZeneca, which has pledged it won’t make a profit on the vaccine during the pandemic, has reached agreements with governments and international health organizations that put its cost at about $2.50 a dose. Pfizer’s vaccine costs about $20, while Moderna’s is $15 to $25, based on agreements the companies have struck to supply their vaccines to the U.S. government.

All three vaccines must be approved by regulators before they can be widely distributed.

Oxford researchers and AstraZeneca stressed they weren’t competing with other projects and said multiple vaccines would be needed to reach enough of the world’s population to end the pandemic.

“We need to be able to make a lot of vaccine for the world quickly, and it’s best if we can do it with different technologies so that if one technology runs into a roadblock, then we’ve got alternatives, we’ve got diversity,″ professor Sarah Gilbert, a leader of the Oxford team, told The Associated Press. “Diversity is going to be good here, but also in terms of manufacturing, we don’t want to run out of raw materials.”

AstraZeneca said it will immediately apply for early approval of the vaccine where possible, and it will seek an emergency use listing from the World Health Organization, so it can make the vaccine available in low-income countries.

The AstraZeneca trial looked at two different dosing regimens. A half-dose of the vaccine followed by a full dose at least one month later was 90% effective. Another approach, giving patients two full doses one month apart, was 62% effective.

That means that, overall, when both ways of dosing are considered, the vaccine showed an efficacy rate of 70%.

Gilbert said researchers aren’t sure why giving a half-dose followed by a larger dose was more effective, and they plan to investigate further. But the answer is probably related to providing exactly the right amount of vaccine to get the best response, she said.

“It’s the Goldilocks amount that you want, I think, not too little and not too much. Too much could give you a poor quality response as well ...,″ she said. “I’m glad that we looked at more than one dose because it turns out to be really important.”

The vaccine uses a weakened version of a common cold virus that is combined with genetic material for the characteristic spike protein of the virus that causes COVID-19. After vaccination, the spike protein primes the immune system to attack the virus if it later infects the body.

The above is proof of solution as authorised distributor

https://www.google.com/url?sa=t&source=web&rct=j&url=https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download%3Fid%3D106130%26name%3DEA_GA_ATTACHMENTS&ved=2ahUKEwjpxZyOxdntAhUd4XMBHSotCBEQFjAAegQIARAB&usg=AOvVaw2RlIpGS5HdoOUvDqryMRVX&cshid=1608363775762

Free to population but gov foot the bill( pay for it) so what?

No 3nd party but authorised dealer